{"metadata": {"organization_names": [], "person_names_verified": ["^thompson bowles", "mauro bove", "joseph c. mcnay", "richard j. hindin", "allan l. goldstein", "david r. crockford", "j.j. finkelstein", "steven m. skolnick", "clifford a. teller"], "organization_names_verified": ["maxim group", "{maxim group llc", "regenerx biopharmaceuticals inc", "supreme court", "cooley llp", "the depository trust company", "reznick group p.c.", "maxim group llc", "regenerx biopharmaceuticals, inc.", "corporation records services", "lowenstein sandler", "sigma tau finanziaria"], "topics": [], "entities_rejected": [], "person_names": [], "agreement_id": "8d716f53a4367ac84c65dc1ba53b46c8919f1fb872369d9dd4dc92527a6e2c89", "vars": {}, "terms": ["**(**\u201c", "**)**", "**ANNEX I**", "**ANNEX II**", "**Accepted by the Representative, acting for themselves and as Representative of the Underwriters named on**", "**Company**", "**Form Lock-Up Agreement**", "**Form of Warrant Agreement**", "**Issuer-Represented General Free Writing Prospectus**", "**Lock-Up Parties**", "**Number of Firm**", "**Number of Secondary**", "**Offering Units to be**", "**Option Shares**", "**Over-Allotment**", "**Purchased from the**", "**Purchased**", "**REGENERX BIOPHARMACEUTICALS, INC.**", "**Reznick**\u201d", "**SCHEDULE A**", "**SCHEDULE B**", "**SCHEDULE C**", "**Schedule A**", "**Shares to be**", "**TOTAL**", "**UNDERWRITING AGREEMENT**", "**Underwriter**", "**Underwriters**", "**[] UNITS**", "**attached hereto, as of the date first written above:**", "*As Representative of the Underwriters*", "*Schedule A*", "*[Signature Pages Follow]*", "*hereto*", "*named on*", "*provided, however,*", "\u201c**Affiliates**\u201d", "\u201c**Agreement**\u201d", "\u201c**Benefit Arrangements**", "\u201c**COBRADesk**\u201d", "\u201c**Closing Date**", "\u201c**Closing**", "\u201c**Code**\u201d", "\u201c**Commission**\u201d", "\u201c**Common Shares**\u201d", "\u201c**Company**\u201d", "\u201c**Consents**\u201d", "\u201c**DTC**\u201d", "\u201c**Default Units**\u201d", "\u201c**EDGAR**\u201d", "\u201c**ERISA Affiliate**\u201d", "\u201c**ERISA**\u201d", "\u201c**Effective Date**\u201d", "\u201c**Electronic Prospectus**\u201d", "\u201c**Employee Plans**", "\u201c**Environmental Laws**\u201d", "\u201c**Exchange Act**\u201d", "\u201c**FINRA**\u201d", "\u201c**Firm Unit**\u201d", "\u201c**General Disclosure Package**\u201d", "\u201c**Intellectual Property**\u201d", "\u201c**Issuer-Represented Free Writing Prospectus**\u201d", "\u201c**Issuer-Represented General Free Writing Prospectus**\u201d", "\u201c**Issuer-Represented Limited-Use Free Writing Prospectus**\u201d", "\u201c**Lien**\u201d", "\u201c**Lock-Up Parties**\u201d", "\u201c**Marketing Materials**\u201d", "\u201c**Material Adverse Change**\u201d", "\u201c**Material Adverse Effect**\u201d", "\u201c**Money Laundering Laws**\u201d", "\u201c**OFAC**\u201d", "\u201c**Offering**", "\u201c**Option Closing Date**\u201d", "\u201c**Option Units**\u201d", "\u201c**Over-allotment Option**\u201d", "\u201c**Person**\u201d", "\u201c**Preliminary Prospectus**", "\u201c**Prospectus Delivery Period**\u201d", "\u201c**Prospectus**", "\u201c**Registration Statement**", "\u201c**Relevant Security**\u201d", "\u201c**Representative**\u201d", "\u201c**Representative\u2019s Securities**", "\u201c**Representative\u2019s Warrant**\u201d", "\u201c**Road Show Expenses**\u201d", "\u201c**Rule 424(b)**\u201d", "\u201c**Rule 462(b) Registration Statement**\u201d", "\u201c**Rules and Regulations**\u201d", "\u201c**SEC Documents**\u201d", "\u201c**Sarb-Ox**\u201d", "\u201c**Securities Act**\u201d", "\u201c**Securities**\u201d", "\u201c**Statutory Prospectus**\u201d", "\u201c**Time of Sale**\u201d", "\u201c**Underwriters**\u201d", "\u201c**Underwriters\u2019 Counsel**\u201d", "\u201c**Underwriters\u2019 Information**\u201d", "\u201c**Units**", "\u201c**Warrant Agreement**\u201d", "\u201c**Warrants**\u201d", "\u201c**knowledge of the Company**\u201d", "\u201c**material**\u201d"]}}